Corrigendum to “Metformin-mediated protection against doxorubicin-induced cardiotoxicity” [Biomed. Pharmacother., 180, (2024), 117535] - 28/04/26

Ming-Li Sun ^{a, ⁎} , Jun-Min Dong ^a, Chen Liu ^a, Pu Li ^a, Chao Zhang ^b, Jie Zhen ^c, Wei Chen ^{c, ⁎}

^a Phase I Clinical Trial Research Center, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038, China 

^b Department of Ultrasonography, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing 100020, China 

^c Department of Intensive Care Unit, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038, China 

^⁎ Corresponding authors.

Le texte complet de cet article est disponible en PDF.